- For Some, ‘Tis the Season for Loneliness. Experts Offer Tips to Stay Connected
- Taking a GLP-1 Medication? Here’s Tips to Holiday Eating
- Bird Flu Virus in Canadian Teen Shows Mutations That Could Help It Spread Among Humans
- Flu, COVID Vaccination Rates Remain Low as Winter Nears
- ’10 Americas:’ Health Disparities Mean Life Expectancy Varies Across U.S.
- Short-Term Hormone Therapy for Menopause Won’t Harm Women’s Brains
- Could a Vitamin Be Effective Treatment for COPD?
- Woman Receives World’s First Robotic Double-Lung Transplant
- Flavored Vapes Behind Big Surge in U.S. E-Cigarette Sales
- Reading Beyond Headline Rare For Most on Social Media, Study Finds
Health Highlights: July 23, 2021
Here’s some of HealthDay’s top stories for Friday, July 23:
Arguing for & against approval of controversial Alzheimer’s drug. The FDA earlier this month gave its OK to the first new Alzheimer’s drug in years — despite its own panel voting 10-1 against approval. Now, some doctors and hospitals are refusing to use the expensive drug, called Aduhelm. Who’s right? Read more
Are antibiotics the only answer for UTIs? Millions of women are stricken with a urinary tract infection each year, and the typical response from their doctors is a prescription for antibiotics. But is that really solving the problem?Read more
A new drug offers hope against psychosis. Hallucinations, delusions, agitation: Hallmarks of psychotic episodes, which can incapacitate the frail or ill and create a huge burden for caregivers. Now, research suggests that a drug that’s been effective against Parkinson’s psychosis may work for other forms of the condition. Read more
Copyright © 2024 HealthDay. All rights reserved.